NFKB1 and neoplasm: demonstrated that pathogenic bacteria in the gut can induce the release of pro-inflammatory cytokines, activating inflammatory signaling pathways such as nuclear factor kappa B (NF-κB), ultimately leading to tumor initiation and progression.